(Q46255425)

20 December 2017

title

MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway (English)

1 reference

20 December 2017

0 references

1 reference

hepatocellular carcinoma

1 reference

Xin Yang

1

1 reference

20 December 2017

Lei Liang

2

1 reference

20 December 2017

Xiao-Fei Zhang

3

1 reference

20 December 2017

Hu-Liang Jia

4

1 reference

20 December 2017

Yi Qin

5

1 reference

20 December 2017

Xu-Chao Zhu

6

1 reference

20 December 2017

Xiao-Mei Gao

7

1 reference

20 December 2017

Peng Qiao

8

1 reference

20 December 2017

Yan Zheng

9

1 reference

20 December 2017

Yuan-Yuan Sheng

10

1 reference

20 December 2017

Jin-Wang Wei

11

1 reference

20 December 2017

Hai-Jun Zhou

12

1 reference

20 December 2017

Ning Ren

13

1 reference

20 December 2017

Qing-Hai Ye

14

1 reference

20 December 2017

Qiong-Zhu Dong

15

1 reference

20 December 2017

Lun-Xiu Qin

16

1 reference

20 December 2017

language of work or name

English

0 references

publication date

5 June 2013

1 reference

20 December 2017

published in

Hepatology

1 reference

20 December 2017

volume

58

1 reference

20 December 2017

page(s)

158-170

1 reference

20 December 2017

issue

1

1 reference

20 December 2017

MicroRNAs: small RNAs with a big role in gene regulation

cites work

1 reference

21 January 2018

1 reference

A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia

21 January 2018

1 reference

MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma

21 January 2018

1 reference

MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity

21 January 2018

1 reference

Identification of metastasis-related microRNAs in hepatocellular carcinoma.

21 January 2018

1 reference

MicroRNA signatures in human cancers

21 January 2018

1 reference

Widespread microRNA repression by Myc contributes to tumorigenesis

21 January 2018

1 reference

Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model

21 January 2018

1 reference

Specific microRNAs are downregulated in human thyroid anaplastic carcinomas.

21 January 2018

1 reference

MicroRNA expression, survival, and response to interferon in liver cancer

21 January 2018

1 reference

Deregulated expression of miR-26a and Ezh2 in rhabdomyosarcoma

21 January 2018

1 reference

Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer

21 January 2018

1 reference

The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo

21 January 2018

1 reference

MicroRNA-26a promotes cholangiocarcinoma growth by activating β-catenin

21 January 2018

1 reference

MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN.

21 January 2018

1 reference

Osteogenic differentiation of human adipose tissue-derived stem cells is modulated by the miR-26a targeting of the SMAD1 transcription factor

21 January 2018

1 reference

MicroRNA-26a/b and their host genes cooperate to inhibit the G1/S transition by activating the pRb protein

21 January 2018

1 reference

MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2

21 January 2018

1 reference

MYC stimulates EZH2 expression by repression of its negative regulator miR-26a

21 January 2018

1 reference

Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship

21 January 2018

1 reference

Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.

21 January 2018

1 reference

Significance of CD90+ cancer stem cells in human liver cancer

21 January 2018

1 reference

Down-regulation of microRNA-26a promotes mouse hepatocyte proliferation during liver regeneration

21 January 2018

1 reference

Tumor-specific expression of microRNA-26a suppresses human hepatocellular carcinoma growth via cyclin-dependent and -independent pathways

21 January 2018

1 reference

Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression

21 January 2018

1 reference

Interleukin-6 induces prostate cancer cell growth accompanied by activation of stat3 signaling pathway .

21 January 2018

1 reference

Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor.

21 January 2018

1 reference

Interleukin-6 trans-signalling differentially regulates proliferation, migration, adhesion and maspin expression in human prostate cancer cells

21 January 2018

1 reference

Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production

21 January 2018

1 reference

Inhibition of STAT3 signaling blocks the anti-apoptotic activity of IL-6 in human liver cancer cells

21 January 2018

1 reference

STATs in cancer inflammation and immunity: a leading role for STAT3

21 January 2018

1 reference

Mcl-1 overexpression in hepatocellular carcinoma: a potential target for antisense therapy

21 January 2018

1 reference

Specific COX-2 inhibitor NS398 induces apoptosis in human liver cancer cell line HepG2 through BCL-2.

21 January 2018

1 reference

Activation of stat3 in human melanoma promotes brain metastasis.

21 January 2018

1 reference

Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis.

21 January 2018

1 reference

MicroRNAs as oncogenes and tumor suppressors

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/HEP.26305

1 reference

20 December 2017

PubMed ID

23389848

1 reference

20 December 2017